Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...
As the United States braces for the monster snow storm barreling across the nation, many are panic-buying essentials.
Detailed price information for Arbutus Biopharma Corp (ABUS-Q) from The Globe and Mail including charting and trades.
Asianet Newsable on MSN
ABUS stock on track for biggest intraday drop in over 5 years – what’s the issue around its patent in Europe?
The European Patent Office revoked its patent following opposition proceedings brought by affiliates of Moderna and Merck.
Stocktwits on MSN
MOS stock sees red as cheaper Chinese imports weigh on Q4 operations
Oppenheimer downgraded Mosaic to ‘Perform’ from ‘Outperform’. ・Tight sulfur market conditions are expected to persist into the first half of 2026, continuing to weigh on Mosaic’s outlook, the ...
The U.S. stock market sank sharply in early trading, with investors increasingly skittish about the strength of the artificial intelligence boom. The S&P 500, which set a record high in late October, ...
Netflix is the same stock it was on Friday, trading for the same valuation. Only the per-share price has changed. After close of trading on Friday, Netflix's 10-for-1 stock split, first announced two ...
Mr. Malkiel is an American economist and financial executive. His 50-year-old book, “A Random Walk Down Wall Street,” is widely credited with popularizing stock index funds. Stock markets regularly go ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results